Treatment uses electric pulses to kill prostate cancer cells while minimising risks of incontinence and sexual dysfunction.

Jones Trading reiterated a Buy rating on ORIC Pharmaceuticals stock with a price target of $17.00, as shares traded at $11.23. The stock has shown remarkable momentum, gaining over 20% in the past ...

On 8th day of testimony, PM contends he didn't thwart telecom reforms tied to charges against him, blasts prosecution: 'For 8 ...

Whether you're looking to have some solo fun or experiment with a partner (or two), these come with an expert seal of approval.

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

The Breconshire Friends of Prostate Cymru were overwhelmed by the support for its inaugural Big Breakfast held at Brecon’s ...

Dr. Jeff Bohmer, Medical Director of the Emergency Department at Northwestern Medicine Central DuPage Hospital, joins Bob Sirott to talk about a study that looks at the correlation of an increased ...

Sir Elton John has bounced back after undergoing cancer and hip surgery, but even the Rocket Man admitted one lyric from his ...

Understanding prostate cancer and the role genetics play can be very important for your health. With one in nine men affected by this disease, scientists at Hartford ...

Advanced prostate cancer incidence and mortality rates have increased in California since 2010, which could be due to past ...

Sir Elton John has opened up about his health battles in recent years, including losing his eyesight and suffering from ...

Elton John has been open about his health struggles in recent years, including suffering from severe eye infections, diabetes ...